Stockwinners Market Radar for November 27, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:46 EST Tech Data approves deal to be acquired by Apollo at $145/shr, up from $130/shr - Tech Data (TECD) announced that it has entered into an amendment to its previously announced definitive agreement in which Tiger Midco, LLC, an affiliate of funds managed by affiliates of Apollo Global Management (APO), will acquire all of the outstanding shares of Tech Data common stock. The Amendment provides that the consideration to be received by holders of Tech Data common stock has been increased to $145 per share in cash from $130 per share in cash, among certain other changes. The Amendment was unanimously approved by the Board of Directors of Tech Data, and the revised purchase price represents an 11.5% increase in the price per share of Tech Data's common stock provided in the Original Agreement. The revised purchase price also represents a 30.2% premium to the unaffected closing share price of Tech Data's common stock ended Oct. 15, 2019, the last trading day prior to published market speculation regarding a potential transaction involving Tech Data. The revised transaction has an enterprise value of approximately $6.0B. Pursuant to the "go-shop" provisions of the Original Agreement, on November 23, 2019, Tech Data received a "Company Takeover Offer" from another bidder. On November 24, 2019, the Tech Data Board of Directors unanimously determined, in consultation with its legal and financial advisors, that the Competing Offer constituted a "Company Superior Proposal" as defined in the Original Agreement and notified Parent of its determination. In response, on November 27, 2019, Parent submitted a revised proposal with the terms set forth in the Amendment. After considering Parent's revised proposal, later in the day on November 27 the Tech Data Board of Directors determined that the Competing Offer no longer constituted a Company Superior Proposal and determined to enter into the Amendment with Parent. The Tech Data Board of Directors has unanimously approved the Amendment and recommends that Tech Data shareholders vote in favor of the transaction.

18:26 EST Fly Intel: After Hours Movers - HIGHER: St Joe (JOE) up 9.1% after entering S&P SmallCap600 index. LOWER: Senseonics (SENS) down 14.8% after equity offering... Quotient (QTNT) down 6.5% after ending supply agreement with Ortho-Clinical Diagnostics... SRAX (SRAX) down 3.2% after equity offering... Protagonist Therapeutics (PTGX) down 1.2% after equity offering. Movers as of 18:15ET.

17:44 EST Elliott Associates reduce Citrix stake to 5.3M shares from 6.1M shares - In a regulatory 13D/A filing, Citrix disclosed that Elliott Associates has decreased its holding of its common stock to 5.3M shares from 6.1M shares. Its combined economic exposure to the stock now represents about 4.9% of shares outstanding.

17:30 EST Fastly director sells 85K shares of common stock - In a regulatory filing, Fastly disclosed that its director David Hornik sold 85K shares of common stock on November 25th. The total transaction size was $1.94M.

17:24 EST S&P announces changes to S&P 400, 500, 600 indices - W.R. Berkley (WRB) will replace Viacom (VIA, VIAB) in the S&P 500, RLI Corp. (RLI) will replace W.R. Berkley in the S&P MidCap 400, and The St. Joe Co. (JOE) will replace RLI in the S&P SmallCap 600 prior to the open of trading on Thursday, December 5. S&P 500 constituent CBS (CBS) is acquiring Viacom in a deal expected to be completed soon pending final conditions. Post acquisition, CBS will change its name to ViacomCBS and will trade on the NASDAQ stock exchange under ticker "VIAC."

17:18 EST RLI Corp. to replace W. R. Berkley in S&P 400 at open on 12/5

17:09 EST NEJM publishes Ebola trial results backing 'superiority' of REGN-EB3 to ZMapp - Regeneron Pharmaceuticals announced that the New England Journal of Medicine, NEJM, published results from the randomized controlled PALM trial showing that Regeneron's REGN-EB3 and another investigational agent provided the highest overall survival rates among four investigational treatments for Ebola virus disease. Monoclonal antibody treatments REGN-EB3, mAb114 and ZMapp and the small molecule antiviral agent remdesivir were given to a trial population of 681 patients who had Ebola during the ongoing outbreak in the Democratic Republic of the Congo, DRC. REGN-EB3, a triple-antibody cocktail, demonstrated superior efficacy compared to the ZMapp control arm across multiple measures, including the primary endpoint of mortality at day 28, 33.5% with REGN-EB3 versus 51.3 percent with ZMapp, p=0.002, and secondary endpoint of reduction of the number of days until the Ebola virus was no longer detected in the bloodstream.

17:00 EST NXP Semiconductors director sells 21.1K shares of common stock - In a regulatory filing, NXP Semiconductors disclosed that its Technology/Operations EVP David Reed sold 21.1K shares of common stock on November 25th. The total transaction size was $2.49M.

16:17 EST Lilis Energy discloses notice of NYSE listing deficiency - Lilis Energy announced that on November 21, 2019 it received a deficiency letter from the NYSE, indicating that the company did not meet certain of the NYSE American continued listing standards. The Letter states that the company is below compliance with the continued listing standards as set forth in Section 1003(a)(i)-(iii) of the Company Guide because it has reported a stockholders' equity deficiency as of September 30, 2019 and net losses in its five most recent fiscal years ended December 31, 2018. The company intends to submit a detailed plan of compliance advising the NYSE American of the actions the company has taken, or plans to take, that would bring it into compliance with the NYSE American's continued listing standards within 18 months of receipt of the Letter. As previously announced, the Board of Directors of the company has formed a Special Committee and engaged a financial advisor tasked with reviewing and evaluating strategic alternatives that may enhance the value of the company.

16:09 EST Gartner director sells 4.2K shares of common stock - In a regulatory filing, Gartner disclosed that its director Anne Fuchs sold 4.2K shares of common stock on November 25th-26th. The total transaction size was over $670K.

15:51 EST Churchill Downs appoints William Farmer as Equine Medical Director - Churchill Downs announced the hiring of William Farmer, DVM as Equine Medical Director, a position that will oversee equine safety and care at all CDI racetracks. Farmer recently served as official veterinarian for the California Horse Racing Board and out-of-competition coordinator and consulting veterinarian for Breeders' Cup Ltd.

15:04 EST Amicus treatment of CLN3 Batten disease granted FDA orphan status - Amicus Therapeutics' treatment of CLN3 Batten disease granted FDA orphan status, according to a post to the agency's website. Reference Link

13:34 EST iRobot down 5% after court denies request for preliminary injunction - Shares of iRobot are down over 5% in afternoon trading after SharkNinja announced last night that it "claimed an early victory" in the patent infringement lawsuit that iRobot initiated in the United States District Court for the District of Massachusetts. "In its attempt to dominate the robotic vacuum cleaner market and eliminate more affordable options for consumers, on October 15, 2019, iRobot filed a motion for a preliminary injunction alleging infringement of three of its patents and seeking to stop sales of SharkNinja's IQ robot during the holiday season. After receiving SharkNinja's response, iRobot withdrew its motion with respect to one of the three patents, but persisted in seeking an injunction with respect to the other two. As SharkNinja expected, the court denied iRobot's motion because iRobot failed to show that it would likely prevail on its infringement allegations as to the two patents. SharkNinja demonstrated that it knew of the asserted patents and specifically designed its products so they would not infringe. The court agreed with SharkNinja on all points, writing that 'SharkNinja has raised substantial questions regarding iRobot's infringement allegations,' and denying iRobot's motion for preliminary injunction," SharkNinja stated in its press release reporting the verdict last night. The company added: "While vindicated by today's outcome, SharkNinja will continue to vigorously defend itself in this case and is confident that it will ultimately prevail against iRobot's infringement allegations, which it believes are meritless." Near 1:30 pm ET on Wednesday, iRobot shares are down $2.55, or 5.6%, to $43.15.

13:13 EST Rockstar says Red Dead Redemption 2 for PC is coming to Steam on December 5 - Rockstar Games is a video game developer and publisher and a development division of video game publisher Take-Two Interactive based in New York City, owned by Take-Two Interactive. Reference Link

12:43 EST General Dynamics confirms $731.8M Navy contract award - General Dynamics Mission Systems announced that it has been awarded a $731.8M cost-plus-award-fee and firm-fixed-price indefinite delivery/indefinite quantity sole-source contract for the Mobile User Objective System, or MUOS, ground system sustainment. MUOS is a next-generation satellite communications system that provides secure voice and data communications for U.S. forces worldwide. The contract was awarded by the U.S. Navy on November 8.

12:10 EST Texas AG announces settlement agreement with T-Mobile on Sprint merger - Texas Attorney General Ken Paxton announced that his office reached a settlement with T-Mobile (TMUS) resolving the state's antitrust claims against the proposed merger of mobile wireless telecommunications service providers Sprint (S) and T-Mobile. The agreement is designed to prevent the New T-Mobile from increasing prices for wireless services on Texans for five years after the merger is complete. The agreement also commits the New T-Mobile to build out a 5G network throughout Texas, including rural areas of our state, during the next six years. Terms of the agreement include requirements that the New T-Mobile: Give all Texas customers access to the same or better unlimited talk, text, and data rate plans as those offered by T-Mobile as of the date of the agreement for the next five years; Give all Texas customers access to T-Mobile limited data rate plans at a cost far below what is currently offered in the industry; Commit to provide 5G wireless broadband coverage to areas where most Texans live, including most Texans living in rural portions of the state within the next three years and to expand that 5G coverage dramatically within the next six years; Offer Texas residents that are currently employed by Sprint and T-Mobile substantially similar employment with the New T-Mobile. Reference Link

12:00 EST Coeur Mining falls -7.0% - Coeur Mining is down -7.0%, or -47c to $6.13.

12:00 EST Myovant Sciences rises 15.1% - Myovant Sciences is up 15.1%, or $2.26 to $17.28.

12:00 EST Phoenix New Media rises 73.5% - Phoenix New Media is up 73.5%, or $1.35 to $3.19.

11:35 EST B.O.S. Better Online appoints Ziv Dekel as chairman of the board - B.O.S Better Online Solutions announced that Ziv Dekel has been appointed chairman of the Board. Dekel has been a BOS Director since June 2015. Over the past nine years, Dekel has provided strategic consulting for a wide range of businesses in diverse industries.

11:09 EST Seelos Therapeutics announces dosing of Phase 1 PK/PD study of SLS-002 - Seelos Therapeutics announced dosing of the first subjects in a Phase I Pharmacokinetic and Pharmacodynamic profile study, SLS-002-102. SLS-002-102 is a two-part, randomized, double-blind, placebo-controlled, parallel and crossover study of intranasal and intravenous ketamine which plans to enroll 62 healthy volunteers. 48 subjects in Part A will be randomized into four arms to receive either 30mg, 75mg, 90mg of SLS-002 or placebo over 13 days. 14 subjects in Part B will be randomized into three arms; 60mg of IV ketamine followed by 60mg SLS-002, 60mg SLS-002 followed by 60mg of IV ketamine, or placebo over 25 days. Preliminary data from this study is expected in the first quarter of 2020. Upon successful completion of the Phase I studies, Seelos plans to conduct a Proof of Concept study of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder.

10:30 EST Evolent Health says Passport management to protest Kentucky Medicaid decision - Evolent Health announced that its partner Passport Health Plan received notification from the Kentucky Cabinet for Health and Family Services that Passport has not been awarded a Kentucky managed Medicaid contract for the next contract period. The award, which was announced by Governor Bevin's administration, is for the contract term commencing July 1, 2020. Passport management has indicated its intent to protest the decision. "We firmly believe this decision, if upheld, is detrimental to the health and wellbeing of the residents of the Commonwealth of Kentucky and we fully support Passport's intent to protest this outcome," said Evolent Health CEO Frank Williams. Evolent will continue to provide services to Kentucky Medicaid beneficiaries through the existing contract period ending June 30, 2020, independent of the outcome of Passport's protest.

10:25 EST Silver Lake buys $500M stake in Manchester City owner at $4.8B valuation - City Football Group announced earlier that private equity firm Silver Lake has signed a definitive agreement to make a $500M equity investment, equivalent to just over 10% of the company's post-investment value. The deal values City Football Group at $4.8B post-investment. CFG is the owner of soccer clubs and related businesses, including Premier League Champions Manchester City FC, New York City FC, Melbourne City FC, Yokohama F. Marinos in Japan, Club Atletico Torque in Uruguay, Girona FC in Spain and Sichuan Jiuniu FC in China. The proceeds from the investment will be used by City Football Group to fund international business growth opportunities and develop further CFG technology and infrastructure assets. The Fly notes that CFG's Manchester City competes in the Premier League with publicly-traded Manchester United (MANU), whose shares are up 14% to $19.04 in morning trading in New York. The Fly also notes that The New York Post's Josh Kosman reported on November 4 that Silver Lake, which already owns close to a 10% stake in Madison Square Garden (MSG), was seeking to buy a big stake in the Knicks and Rangers before the teams are spun off into a publicly traded company. Another publicly-traded owner of a sports team is the Liberty Braves Group (BATRA), owner of MLB's Atlanta Braves.

10:20 EST Deere management says 'still in a replacement market' - Management said the company sees Tractor segment recovery moving forward due to replacement demand. Tractor order book extends to March, which is ahead of last year. OUtlook for dairy segment remains stable. Management expects FY19 net cash income to increase 7% to $113B. Comments provided during Q4 earnings conference call.

09:49 EST Evolent Health trading resumes

09:03 EST Aptevo treatment of acute myelogenous leukemia granted FDA orphan status - Aptevo Therapeutics' was granted orphan designation from the FDA for its treatment of acute myelogenous leukemia, according to a post to the agency's website. Reference Link

08:59 EST Ideanomics partners with city of Qingdao for EV sales and finance center - Ideanomics has announced an agreement with Chengyang Investment, representing the Chenyang District of Qingdao, Shandong province. Ideanomics' MEG division will acquire a large-scale facility for the promotion of its battery partners, as well as its manufacturer alliance, for large-scale fleet operators looking to transition to clean energy vehicles. The facility will be a showcase enabling EV manufacturers and EV technology partners a venue focused entirely on EV, EV infrastructure, and financing solutions. The facility, already built, will be renovated as part of the deal, and is expected to come online in 2020.

08:35 EST Trinity Place

08:35 EST Trinity Place

08:20 EST Schmitt Industries Inc completes sale of SBS business line for $10.5M - Schmitt Industries announced that it has closed on the sale of its Schmitt Dynamic Balance Systems business line to Tosei Engineering Corp. and Tosei America for a purchase price of $10.5M in cash, subject to customary post-closing adjustments. In conjunction with the sale, Tosei has entered into a 10-year triple net lease of Schmitt's 28th Avenue manufacturing facility. Base rent for the first twelve months will be approximately $23K a month. Schmitt will allocate net proceeds among organic investment opportunities, acquisitions, and capital returns to shareholders based on expected return on invested capital.

08:06 EST Agraflora awarded Health Canada research license at Winnipeg edibles facility - AgraFlora Organics International announced the Company's subsidiary, The Edibles and Infusions Corporation has been awarded a cannabis research licence from Health Canada under the Cannabis Regulations Act. The Research License equips AgraFlora with the ability to develop cannabis edible formulations, as well as perform human sensory testing for taste, appearance, aroma and texture at its 51,500 square foot edibles manufacturing facility located in Winnipeg, Manitoba. The Research License also allows AgraFlora to possess and store dry cannabis, cannabis oils/concentrates and cannabis edibles. The Company is preparing to immediately begin various formulation and product development campaigns upon the receipt of THC/CBD distillate at its on-site 750 square foot, pharmaceutical grade laboratory. AgraFlora also announces that its roster of food engineers, nutritionists and scientists will be travelling to the Winnipeg Edibles Facility to assist with optimizing bioavailability, consistent dosing protocols and the flavouring of its formulations. The Company's in-house food science consultancy arm is comprised by experienced microbiologists, as well as certified bakers trained by the American Institute of Baking.

08:04 EST Taronis Technologies says 'on schedule' to complete Taronis Fuels spin-off - Taronis Technologies announced that it is on schedule to complete the Taronis Fuels spin-off as previously scheduled. November 29, 2019 is the record date, which is the critical date in which shareholders must be a shareholder of record in Taronis Technologies to be eligible to receive the stock dividend. Shareholders of record must then hold those same shares until the stock distribution is completed on December 5th. Any shareholder that sells their Taronis Technologies stock prior to the distribution will forfeit any rights to the distribution. Taronis Fuels expects to begin initial trading on the OTCQB. The Company has already explored uplisting requirements and believes it has the ability to satisfy all listing requirements for the New York Stock Exchange shortly after the spin-off is complete. Uplisting is expected to be a top priority for management in early 2020.

07:57 EST Kyocera proposes to acquire shares it does not own of AVX for $19.50 per share - Kyocera Corporation announced that it has made a proposal to a special committee of the board of directors of AVX Corporation to acquire all outstanding shares of common stock of AVX not owned by Kyocera for $19.50 per share in cash. The proposal represents a 29.7% premium over the closing price as of November 26, and 27.4%, 27.6% and 27.0% premium over a 1-, 3- and 6- month average closing share price, respectively. Kyocera currently owns approximately 72% of AVX's outstanding shares of common stock. If the transaction is completed, AVX would become a wholly owned subsidiary of Kyocera. "The proposal will be reviewed by the special committee. No assurance can be given whether such proposal will lead to a transaction or as to any of the terms or conditions of such transaction. Kyocera does not intend to disclose any developments unless or until it otherwise deems further disclosure is appropriate or required," the company stated.

07:33 EST Burlington Stores CEO: FY20 sales and earnings growth may be bit lower than FY19 - In his Q/A remarks accompanying Burlington Stores' Q3 earnings call yesterday, CEO Michael O'Sullivan said: "Directionally, you shouldn't be surprised if the guidance we give for sales and earnings growth (for FY20) is a little bit lower than the guidance we gave coming into this year. And to be clear, this does not signal a change in our long-term growth outlook, but rather an attempt to strengthen the business and move it towards a somewhat more aggressive chase mode a more aggressive off-price mode. I'm very confident that by moving this direction, by becoming more off-price, we'll be even more successful in driving profitable growth in the next few years."

07:19 EST SAIC wins position on EPA contract - The Environmental Protection Agency awarded Science Applications International Corp. a position on an indefinite-delivery, indefinite-quantity contract to provide outreach and technical support services to an Environmental Protection Agency program designed to help agencies and private organizations comply with Clean Air Act. The multiple-award contract is worth more than $81M over a five-year period for all awardees.

07:18 EST Pure Acquisition Corp. enters business combination agreement with HighPeak Energ - Pure Acquisition announced that it has entered into a Business Combination Agreement with, among others, HighPeak Energy, a wholly owned subsidiary of Pure formed to effect the business combination, and certain affiliates of HighPeak Energy Partners, and a Contribution Agreement with, among others, HighPeak Energy and Grenadier Energy Partners II. Pursuant to the Business Combination Agreements, a wholly owned subsidiary of HighPeak Energy will merge with and into Pure, with Pure surviving as a wholly owned subsidiary of HighPeak Energy and Pure's existing stockholders receiving one share of common stock of HighPeak Energy for each share of Pure's common stock owned thereby. HighPeak Energy will then acquire certain assets from the HighPeak Funds in exchange for shares of its common stock and certain assets from Grenadier in exchange for shares of its common stock, warrants to purchase shares of its common stock and cash. After giving effect to the business combination, HighPeak Energy will conduct its business as an independent oil and natural gas company engaged in the acquisition, development and production of oil, natural gas and NGL reserves with assets located in the northeastern part of the oil-rich Midland Basin. Upon completion of the business combination, HighPeak Energy intends to list its common stock and warrants for trading on the New York Stock Exchange or the Nasdaq Capital Market under the symbols "HPK" and "HPKWS." Pure's securities are expected to be delisted from the Nasdaq at closing of the business combination concurrently with the NYSE or Nasdaq listing for trading of HighPeak Energy's securities. The transaction was unanimously approved and recommended to Pure's board of directors by a special committee consisting of independent directors of Pure's Board, and is expected to close in the first quarter of 2020, subject to certain closing conditions, including receipt of the requisite shareholder approval. HighPeak Energy Operating Highlights: Contiguous position of greater than 71,000 net acres located primarily in Howard County, with greater than 90% operated, provides the sale and depth of inventory to efficiently develop; Anticipated net production of approximately 12,000 barrels of oil equivalent per day, projected as of the year ended 2019; High oil mix of more than 80% supports a strong operating margin; Approximately 875 drilling locations identified in either the Wolfcamp A and/or Lower Spraberry formations that are planned to be developed with mostly two-mile laterals; Planned pad development in 2020 with four operated rigs reduces the impact of parent/child degradation; Significant recent offset and non-operated activity is quickly de-risking the acreage position. Pursuant to the HPK Business Combination Agreement, HighPeak Energy will acquire, in exchange for 71,150,000, as adjusted in accordance with the HPK Business Combination Agreement, shares of HighPeak Energy common stock, all of the outstanding interests in HPK Energy, which holds certain rights, title and interests in oil and natural gas assets and cash, as well as the right, pursuant to a Contribution Agreement between Grenadier and a subsidiary of HPK, to acquire substantially all of the assets of Grenadier for aggregate consideration of 15,760,000 shares of HighPeak Energy common stock, 2,500,000 warrants to purchase HighPeak Energy common stock and approximately $465M in cash, subject to purchase price adjustments. The closing of the business combination is subject to the requisite approval of Pure's stockholders and the satisfaction of customary conditions. The business combination is expected to close in the first quarter of 2020.

07:12 EST Emerald Health's Pure Sunfarms to supply cannabis products to Alberta - Emerald Health Therapeutics announced that its 50%-owned joint venture Pure Sunfarms has secured a cannabis supply agreement with Alberta Gaming, Liquor & Cannabis to become an official supplier of recreational adult-use cannabis products to the province's licensed private sector retailers including Alberta's only legal online source for recreational cannabis. The AGLC is the wholesaler to private retailers and the only authorized online retailer in Alberta. Pure Sunfarms expects to deliver its first shipment of high-quality dried flower, inclusive of pre-rolls which are anticipated to enter Pure Sunfarms' product lineup, to consumers in Alberta in the weeks and months ahead. Alberta has over 330 licensed stores, more than all other provinces combined. The province reported $164.6M in legal cannabis retail trade sales between January and September 20191, placing it in the top three provinces in Canada, and sales growth of 39% from the second to third quarter.

07:05 EST Intersect ENT appoints Richard Meier as CFO - Intersect ENT (XENT) announced the appointment of Richard Meier as executive VP and CFO effective immediately. Meier previously served as the CFO and senior executive of Owens & Minor (OMI). Meier also serves on the board of BioMarin (BMRN), where he is lead independent director.

07:04 EST Village Farms' Pure Sunfarms signs cannabis supply agreement with Alberta - Village Farms' majority-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has entered into a supply agreement with the Alberta Gaming, Liquor & Cannabis Commission, or AGLC, to supply recreational adult-use cannabis products to Alberta's licensed private retailers, including Alberta's only legal online source for recreational cannabis, AlbertaCannabis.org. The AGLC is the wholesaler to private retailers and the only authorized online retailer in Alberta. Pure Sunfarms expects to begin shipping its branded packaged dried flower, inclusive of pre-rolls, which are anticipated to enter Pure Sunfarms' product lineup, to the AGLC in the coming weeks and months. Alberta represented 21% of total retail trade cannabis sales in Canada for the nine-month period from January to September 2019. Alberta saw month over month sales growth for September 2019 of 4%. Pure Sunfarms' supply agreement with Alberta is its third provincial supply agreement. Combined with its previously announced supply agreements for Ontario and British Columbia, Pure Sunfarms now has access to approximately 64% of the Canadian population.

07:01 EST Aurora Cannabis opens flagship retail store in West Edmonton Mall - Aurora Cannabis announced the grand opening of its flagship retail store at 10:00 a.m. MT on November 27th in the West Edmonton Mall, North America's largest mall. At approximately 11,000 square feet, Aurora has combined both a retail cannabis store and an immersive experiential space, encouraging visitors from around the world to explore unique products and participate in a rotating calendar of programming and events. Aurora's flagship store offers visitors a safe, age-gated retail experience in full compliance with all relevant federal and provincial regulations.

06:27 EST Deere sees FY20 CapEx ~ $1.1B - Compared to FY19 CapEx of $1.12B.

06:21 EST Deere CEO says 'longer-term outlook for our businesses remains healthy' - "Despite present challenges, the longer-term outlook for our businesses remains healthy and points to a promising future for Deere," CEO John May said. "We are particularly encouraged by the adoption of precision technologies and believe we are well-positioned to be a leader in the delivery of smarter, more efficient and sustainable solutions to our customers. At the same time, we are committed to the successful execution of our strategic plan and have initiated a series of measures to create a leaner organizational structure that can operate with more speed and agility. We're confident these steps will lead to improved efficiencies and help the company focus its resources and investments on areas that have the greatest impact on performance."

06:08 EST Orion Engineered Senior Manager buys 2,500 additional shares - Orion Engineered Senior VP, Global Operations, Carlos Quinones has purchased a total of 2,500 common shares of the company at an average price of $18.44 per share in addition to the 8,000 common shares acquired by him August 26 and 7,439 common shares acquired August 27.

05:25 EST TLC enrolls first patient in EXCELLENCE Phase III pivotal clinical trial - TLC announced that the first patient has been enrolled in EXCELLENCE, the Phase III pivotal clinical trial for TLC599 in patients with osteoarthritis, or OA, knee pain. TLC599 is a non-opioid, proprietary BioSeizer sustained release formulation of dexamethasone sodium phosphate intended to manage OA pain for up to six months.

05:21 EST Accenture signs MoU with Snam to study, assess solutions based on IOT tech - Accenture and Snam have signed a memorandum of understanding, or MoU, to study and assess solutions based on Internet of Things, or IOT, technologies to boost innovation and sustainability of energy networks as part of the global strategic push towards an energy transition. Accenture and Snam will research and assess solutions for internet-connected devices and other technologies - such as machine learning and artificial intelligence, edge and fog computing and advanced analytics - to optimize the monitoring and maintenance of infrastructure to make it smarter and more sustainable, generating a positive impact on surrounding regions and communities. Another objective of the collaboration will be to carry out analyses on the growing role of renewable gases such as biomethane and hydrogen on the energy mix of the future.